Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-115 |
Sentence |
denotes |
IFP 35 is an interferon-induced leucine zipper protein that undergoes interferon-regulated cellular redistribution. |
T2 |
116-216 |
Sentence |
denotes |
We have isolated a new human cDNA, named IFP 35, whose expression is regulated by interferons (IFN). |
T3 |
217-316 |
Sentence |
denotes |
Induction of IFP 35 mRNA in HeLa cells by IFN is due, at least in part, to increased transcription. |
T4 |
317-483 |
Sentence |
denotes |
In response to IFN treatment, the expression of IFP 35 mRNA is seen in a wide range of different cell types, including fibroblasts, macrophages, and epithelial cells. |
T5 |
484-578 |
Sentence |
denotes |
The cDNA sequence encodes a 282-amino acid protein with a deduced molecular mass of 31,130 Da. |
T6 |
579-715 |
Sentence |
denotes |
In vitro translation of mRNA obtained by both in vitro transcription and hybrid selection resulted in the synthesis of a 35-kDa protein. |
T7 |
716-824 |
Sentence |
denotes |
Antisera raised against IFP 35 recognized a protein with an apparent molecular mass of 35 kDa in HeLa cells. |
T8 |
825-960 |
Sentence |
denotes |
Amino acid sequence analysis revealed a leucine zipper motif in an alpha-helical configuration at the extreme amino terminus of IFP 35. |
T9 |
961-1074 |
Sentence |
denotes |
Notable IFP 35 is a unique novel leucine zipper protein in that it lacks a basic domain critical for DNA binding. |
T10 |
1075-1124 |
Sentence |
denotes |
IFP 35 can specifically form homodimers in vitro. |
T11 |
1125-1242 |
Sentence |
denotes |
Western blot analysis of fractionated cell extracts indicates increased nuclear localization following IFN treatment. |
T1 |
0-115 |
Sentence |
denotes |
IFP 35 is an interferon-induced leucine zipper protein that undergoes interferon-regulated cellular redistribution. |
T2 |
116-216 |
Sentence |
denotes |
We have isolated a new human cDNA, named IFP 35, whose expression is regulated by interferons (IFN). |
T3 |
217-316 |
Sentence |
denotes |
Induction of IFP 35 mRNA in HeLa cells by IFN is due, at least in part, to increased transcription. |
T4 |
317-483 |
Sentence |
denotes |
In response to IFN treatment, the expression of IFP 35 mRNA is seen in a wide range of different cell types, including fibroblasts, macrophages, and epithelial cells. |
T5 |
484-578 |
Sentence |
denotes |
The cDNA sequence encodes a 282-amino acid protein with a deduced molecular mass of 31,130 Da. |
T6 |
579-715 |
Sentence |
denotes |
In vitro translation of mRNA obtained by both in vitro transcription and hybrid selection resulted in the synthesis of a 35-kDa protein. |
T7 |
716-824 |
Sentence |
denotes |
Antisera raised against IFP 35 recognized a protein with an apparent molecular mass of 35 kDa in HeLa cells. |
T8 |
825-960 |
Sentence |
denotes |
Amino acid sequence analysis revealed a leucine zipper motif in an alpha-helical configuration at the extreme amino terminus of IFP 35. |
T9 |
961-1074 |
Sentence |
denotes |
Notable IFP 35 is a unique novel leucine zipper protein in that it lacks a basic domain critical for DNA binding. |
T10 |
1075-1124 |
Sentence |
denotes |
IFP 35 can specifically form homodimers in vitro. |
T11 |
1125-1242 |
Sentence |
denotes |
Western blot analysis of fractionated cell extracts indicates increased nuclear localization following IFN treatment. |